• M Bürle, H Mende, U Plum, M Bluthardt, M Walka, and G Geldner.
• Klinik für Anästhesiologie, Intensivmedizin, Schmerztherapie und Notfallmedizin, Klinikum Ludwigsburg, Posilipostr. 4, 71640, Ludwigsburg, Deutschland. monica.buerle@kliniken-lb.de
• Anaesthesist. 2009 Jun 1;58(6):594-601.

BackgroundOrnithine transcarbamylase (OTC) deficiency is the most frequent innate disorder of the urea cycle and is X-chromosome linked. The disease normally manifests itself shortly after birth and is fatal when untreated. Due to the different expression and X-chromosomal inheritance the manifestation of symptoms can appear later particularly in girls and young women. The first symptoms are non-specific signs of elevated cerebral pressure as a result of a hyperammonemia, which range from nausea and headache up to cerebral herniation with fatal outcome. Measurement of plasma ammonia levels is a simple yet important screening test for patients with unexpected stupor or delirium.Case ReportsThe two case reports show the clinical range from acute decompensation with acute cerebral herniation followed by fatal outcome to recovery under emergency therapy without substantial neurological deficits.TherapyEmergency treatment consists of symptomatic securing of vital parameters and an immediate reduction in the ammonia level using high calorie, protein-free nutrition to avoid catabolism together with administration of arginine, benzoate or phenyl butyrate. In cases of coma with severe cerebral edema and the threat of a herniation reaction or excessive ammonia levels, emergency hemodialysis must be immediately carried out.ConclusionsIn the clinical routine it is extremely important to consider a metabolic defect at an early phase and among others to determine the ammonia level so that the appropriate treatment can be instigated in time.

18 keywords...

hide…